Lexaria Bioscience (LEXX) Revenue (2017 - 2026)
Lexaria Bioscience's (LEXX) quarterly Revenue came in at $20000.0 in Q1 2026, down 88.51% year-on-year from $174000.0 in Q1 2025, and down 88.51% quarter-over-quarter from $174000.0 in Q3 2025.
Lexaria Bioscience (LEXX) Revenue (2017 - 2026) Analysis & Trends
Lexaria Bioscience has disclosed Revenue across 10 years of filings, most recently posting $20000.0 for Q1 2026.
- Revenue for Q1 2026 came in at $20000.0, down 88.51% year-over-year; the trailing twelve-month figure through Feb 2026 was $368000.0 (down 30.03% YoY), and the FY2025 annual result was $705923.0, up 52.05% from the prior year.
- Revenue came in at $20000.0 for Q1 2026 at Lexaria Bioscience, down from $174000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $183923.0 in Q4 2024 to a low of $20000.0 in Q1 2026.
- The 5-year median for Revenue is $98726.0 (2022), against an average of $105661.0.
- Across the five-year window, Revenue sank 97.72% in 2022 and jumped 624.09% in 2024, its largest moves.
- Lexaria Bioscience's Revenue stood at $97735.0 in 2022, then jumped by 54.78% to $151278.0 in 2023, then advanced by 21.58% to $183923.0 in 2024, then decreased by 5.4% to $174000.0 in 2025, then slumped by 88.51% to $20000.0 in 2026.
- The last three Revenue figures came in at $20000.0 (Q1 2026), $174000.0 (Q3 2025), and $174000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Lexaria Bioscience | 7.17 Mn | 1.65 Mn | 20,000.00 | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 20,000.00 |
| Aug 31, 2025 | 174,000.00 |
| May 31, 2025 | 174,000.00 |
| Feb 28, 2025 | 174,000.00 |
| Nov 30, 2024 | 183,923.00 |
| Aug 31, 2024 | 84,000.00 |
| May 31, 2024 | 84,000.00 |
| Feb 29, 2024 | 145,000.00 |
| Nov 30, 2023 | 151,278.00 |
| Aug 31, 2023 | 30,741.00 |
| May 31, 2023 | 77,707.00 |
| Feb 28, 2023 | 20,025.00 |
| Nov 30, 2022 | 97,735.00 |
| Aug 31, 2022 | 143,800.00 |
| May 31, 2022 | 99,717.00 |
| Feb 28, 2022 | 30,650.00 |
| Nov 30, 2021 | 13,880.00 |
| Aug 31, 2021 | 6.31 Mn |
| May 31, 2021 | 204,055.00 |
| Feb 28, 2021 | 192,006.00 |